Adherence to Tuberculosis Treatment in Paraguay: a Challenge with a Human Face. 2022 Analysis
Article Sidebar
Main Article Content
Abstract
Introduction: Tuberculosis (TB) remains one of the leading causes of death worldwide and a public health problem in Paraguay, where non-adherence to treatment affects 16% of patients. This study aims to identify the factors limiting therapeutic adherence in patients with drug-sensitive TB in Paraguay.
Methodology: A retrospective, cross-sectional, analytical study was conducted using a structured questionnaire applied to 157 TB-diagnosed patients across three health regions between January and May 2022. Adherence was assessed using the Morisky-Green test and analyzed through univariate logistic regression.
Results: 37% of patients were non-adherent to treatment, with significant barriers identified, including inadequate clinic hours (OR = 6.66, p < 0.05), long waiting times (OR = 4.4, p = 0.009), and difficulties obtaining work permits (OR = 5.59, p = 0.04). Sociodemographic and epidemiological characteristics showed that 56% of patients were unemployed during treatment, 35% lived in precarious conditions and 87% were not under directly observed treatment.
Conclusions: The complexity of TB treatment adherence in Paraguay is highlighted, emphasizing the need for comprehensive strategies involving multisectoral actors to address healthcare access barriers and consider socioeconomic factors. The information gathered is crucial for developing health policies that improve patient quality of life and contribute to effective TB control in the country.
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Kyu HH, Maddison ER, Henry NJ et al. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis 2018;18(12):1329–49. Doi: 10.1016/S1473-3099(18)30625-X.
WHO. Global tuberculosis report 2018. World Health Organization; 2018. [Internet]. [Consultado 29 ene 2022]. Disponible en: https://www.who.int/publications/i/item/9789241565646.
World Health Organization. Perfil de Tuberculosis. Paraguay 2020 [Internet]. [Consultado 29 ene 2022]. Disponible en: https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&entity_type=%22country%22&lan=%22ES%22&iso2=%22PY%22
Programa Nacional de Control de la Tuberculosis, Ministerio de Salud Pública y Bienestar Social. Informe Epidemiológico de Tuberculosis. Paraguay, 2024. [Internet]. [Consultado 29 ene 2022]. Disponible en: https://dgvs.mspbs.gov.py/wp-content/uploads/2025/01/Informe-TB-2023.pdf
Programa Nacional de Control de la Tuberculosis. Guía Nacional para el manejo de Tuberculosis. Paraguay, 2017. [Internet]. [Consultado 29 ene 2022]. Disponible en: https://dgvs.mspbs.gov.py/wp-content/uploads/2022/12/guia_nacional_tb_interior_2018_compressed.pdf
World Health Organization. An Expanded DOTS. Framework for Effective Tuberculosis Control. Geneva, Switzerland; 2002 [Internet]. [Consultado 20 jul 2022]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/67232/WHO_CDS_TB_2002.297.pdf?sequence=1
OMS. Implementación de la Estrategia Fin de la TB: Aspectos Esenciales. 2016a ed. Geneva, Switzerland; 2016. [Internet]. [Consultado 14 nov 2020]. Disponible en: http://158.232.12.119/tb/publications/2015/end_tb_essential_spanish_web.pdf
Nezenega ZS, Perimal-Lewis L, Maeder AJ. Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review. Int J Environ Res Public Health 2020;17(15):E5626. Doi: 10.3390/ijerph17155626.
Rondags A, Himawan AB, Metsemakers JF, Kristina TN. Factors influencing non-adherence to tuberculosis treatment in Jepara, central Java, Indonesia. Southeast Asian J Trop Med Public Health 2014;45(4):859–68.
Carvajal-Barona R, Tovar-Cuevas LM, Aristizábal-Grisales JC et al. Barreras asociadas a la adherencia al tratamiento de tuberculosis en Cali y Buenaventura, Colombia, 2012. Revista Gerencia y Políticas de Salud 2017;16(32):68–84.
Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JDH. The Social Determinants of Tuberculosis: From Evidence to Action. Am J Public Health 2011;101(4):654–62. Doi: 10.2105/AJPH.2010.199505.
Maciel EMG de S, Amancio J de S, Castro DB de, Braga JU. Social determinants of pulmonary tuberculosis treatment non-adherence in Rio de Janeiro, Brazil. PLoS One. 2018;13(1):e0190578. Doi: 10.1371/journal.pone.0190578.
Cochran WG. Sampling Techniques. 3rd Edition. John Wiley & Sons, New York, 1977.
Fink A. The Survey Kit. 2nd. Thousand Oaks (CA). SAGE Publications, 2002, pp. 1434.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67–74. Doi: 10.1097/00005650-198601000-00007.
Pagès-Puigdemont N, Valverde-Merino MI, Pagès-Puigdemont N, Valverde-Merino MI. Métodos para medir la adherencia terapéutica. Ars Pharm 2018;59(3):163–72. Doi: 10.30827/ars.v59i3.7387.
Usmanova R, Parpieva N, Liverko I, Davtyan H, Alaverdyan S, Gadoev J. Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020. Eur Resp J 2021;58(suppl 65). Doi: 10.1183/13993003.congress-2021.PA3342.
Worgu GO, Onotai LO, Asuquo EO. Medication Adherence among Pulmonary Tuberculosis Patients in Treatment Centers in a Southern Nigerian Local Government Area: Question Mark on Performance of DOTS Services. Niger Med J 63(5):418–24.
Xu M, Markström U, Lyu J, Xu L. Detection of Low Adherence in Rural Tuberculosis Patients in China: Application of Morisky Medication Adherence Scale. Int J Environ Res Public Health 2017;14(3):248. Doi: 10.3390/ijerph14030248.
Instituto Nacional de Estadísticas. Necesidades Básicas Insatisfechas (NBI): una aproximación a la pobreza estructural, 2012. [Internet]. [Consultado 8 ene 2021]. Disponible en: https://www.dgeec.gov.py/publication-single.php?codec=MTMw
Tanahashi T. Health service coverage and its evaluation. Bull World Health Organ 1978;56(2):295–303.
Instituto Nacional de Estadísticas. Principales resultados de Pobreza Monetaria y Distribución de Ingreso. 2021. [Internet]. [Consultado 3 oct 2022]. Disponible en: https://www.ine.gov.py/Publicaciones/Biblioteca/documento/5626_Boletin_Pobreza%20Monetaria_%20EPHC%202021_INE.pdf
Iparraguirre Usquiano MC. Factores asociados con la adherencia al tratamiento en personas afectadas con tuberculosis en los establecimientos de salud de La Microred El Porvenir Trujillo 2015. 2016. [Internet]. [Consultado 3 oct 2022]. Disponible en: https://repositorio.ucv.edu.pe/handle/20.500.12692/771
Murcia Montaño LM. Evaluación de la adherencia al tratamiento para Tuberculosis en el departamento del Amazonas 2009-2012. 2014. Universidad Nacional de Colombia. [Internet]. [Consultado 1 oct 2022]. Disponible en: https://repositorio.unal.edu.co/handle/unal/21639
González CV. Evaluación de la adherencia al tratamiento de la tuberculosis en el Hospital Regional de Coronel Oviedo, Paraguay, en 2017. Rev Arg Med 2021;9(2).
Lee JY, Kwon N, Goo GY, Cho SI. Inadequate housing and pulmonary tuberculosis: a systematic review. BMC Public Health 2022;22(1):622. Doi: 10.1186/s12889-022-12879-6.
Abd Rani AY, Ismail N, Zakaria Y, Isa MR. A scoping review on socioeconomic factors affecting tuberculosis loss to follow-up in Southeast Asia. Med J Malaysia 2024;79(4):470–6.
Organización Panamericana de la Salud. Marco para la acción colaborativa sobre la tuberculosis y sus comorbilidades. Washington D. C., Estados Unidos, 2023. [Internet]. [Consultado 15 oct 2024]. Disponible en: https://iris.paho.org/handle/10665.2/57796
Adu PA, Spiegel JM, Yassi A. Towards TB elimination: how are macro-level factors perceived and addressed in policy initiatives in a high burden country? Global Health 2021;17(1):11. Doi: 10.1186/s12992-020-00657-1.
Vergara SC, Almagiá EB. Autoeficacia, apoyo social y adherencia al tratamiento en adultos con diabetes mellitus tipo II. Psicología y Salud 2014;24(2):167–74. Doi: 10.25009/pys.v24i2.922.
Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complications 2012;26(1):10–6. Doi: 10.1016/j.jdiacomp.2011.11.002.
Kasahun AE, Sendekie AK, Mekonnen GA, Sema FD, Kemal LK, Abebe RB. Impact of Personal, Cultural and Religious Beliefs on Medication Adherence among Patients with Chronic Diseases at University Hospital in Northwest Ethiopia. Patient Prefer Adherence 2022;16:1787–803. Doi: 10.2147/PPA.S370178.
Shahin W, Kennedy GA, Stupans I. The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: a systematic review. Patient Prefer Adherence 2019;13:1019–35. Doi: 10.2147/PPA.S212046.
Myers B, Bouton TC, Ragan EJ et al. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol. BMC Infect Dis 2018;18(1):488. Doi: 10.1186/s12879-018-3396-y.
Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review. Iran J Public Health 2015;44(1):1–11.
Cáceres G, Calderon R, Ugarte-Gil C. Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression. Ther Adv Infect Dis 2022;9:20499361221095831. Doi: 10.1177/20499361221095831.
Lee CS, Ho CH, Liao KM, Wu YC, Shu CC. The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy. J Infect Public Health 2023;16(11):1778–83. Doi: 10.1016/j.jiph.2023.09.005.
Pedraza-Melo NA, Lavín-Verástegui J, González-Tapia A, Bernal-González I. Factores determinantes en la calidad del servicio sanitario en México: Caso ABC. Entramado 2014;10(2):76–89.
Qiu S, Pan H, Zhang S et al. Is tuberculosis treatment really free in China? A study comparing two areas with different management models. PLoS One 2015;10(5):e0126770. Doi: 10.1371/journal.pone.0126770.
Wingfield T, Boccia D, Tovar M et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 2014;11(7):e1001675. Doi: 10.1371/journal.pmed.1001675.
Hutchison C, Khan MS, Yoong J, Lin X, Coker RJ. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health 2017;17(1):221. Doi: 10.1186/s12889-017-4089-y.
Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J 2014;43(6):1763–75. Doi: 10.1183/09031936.00193413.
Rivera-Lozada O, Rivera-Lozada IC, Bonilla-Asalde CA. Determinantes del acceso a los servicios de salud y adherencia al tratamiento de la tuberculosis. Revista Cubana de Salud Pública 2020;46(4).
Mateus-Solarte JC, Carvajal-Barona R. Factors predictive of adherence to tuberculosis treatment, Valle del Cauca, Colombia. Int J Tuberc Lung Dis 2008;12(5):520–6.
Rupani MP, Dave JD, Parmar VB, Singh MP, Parikh KD. Adverse drug reactions and risk factors for discontinuation of multidrug-resistant tuberculosis regimens in Gujarat, western India. Natl Med J India 2020;33(1):10-14. Doi: 10.4103/0970-258X.308234.
Wang Y, Chen H, Huang Z, McNeil EB, Lu X, Chongsuvivatwong V. Drug Non-Adherence And Reasons Among Multidrug-Resistant Tuberculosis Patients In Guizhou, China: A Cross-Sectional Study. Patient Prefer Adherence 2019;13:1641–53. Doi: 10.2147/PPA.S219920.
Prasad R, Singh A, Gupta N. Adverse drug reactions in tuberculosis and management. The Indian journal of tuberculosis. Indian J Tuberc 2019;66(4):520-532. doi: 10.1016/j.ijtb.2019.11.005.
Organización Panamericana de la Salud. Directrices unificadas de la OMS sobre la tuberculosis. Módulo 4: Tratamiento. Tratamiento de la tuberculosis farmacosensible. Washington D. C., Estados Unidos, 2023 [Internet]. [Consultado 15 oct 2024]. Disponible en: https://iris.paho.org/handle/10665.2/57619
Partners In Health, Observa TB. Asistencia técnica para la medición de estigma de la TB. Paraguay. 2021 [Internet]. [Consultado 15 oct 2024]. Disponible en: https://observatb.org/wp-content/uploads/2023/06/Asistencia_Paraguay.pdf
Alipanah N, Jarlsberg L, Miller C et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med 2018;15(7):e1002595. Doi: 10.1371/journal.pmed.1002595.